Prothrombotic aspects of sickle cell disease. - Wikidata - awgldk - TriplyDB

Prothrombotic aspects of sickle cell disease.

Prothrombotic aspects of sickle cell disease.

http://www.wikidata.org/entity/Q38696998

about

Prothrombotic aspects of sickle cell disease.

http://www.wikidata.org/entity/Q38696998

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Prothrombotic aspects of sickle cell disease.

@en

type

label

Prothrombotic aspects of sickle cell disease.

@en

prefLabel

Prothrombotic aspects of sickle cell disease.

@en

P1433

Q38696998-C59FE52D-CE08-4E28-BE52-65CA121C19F5

P1476

Q38696998-FA3275E4-5451-4D2D-816F-37AFF07FB03F

P2093

Q38696998-F877A6DE-DDAB-422B-91BB-0C5D42BD0C69

P2860

Q38696998-024639B4-FAE2-4035-AD8F-30AC2289B392

Q38696998-02BF3A69-6CF2-4C4E-B317-DBA594430AD5

Q38696998-070D1195-2810-46C8-A0CB-C4BD8D84DEAB

Q38696998-07C9221D-25DB-4E69-B346-250B37328A25

Q38696998-0C996D77-C895-4ED6-B3CA-104F0F3167B6

Q38696998-15388312-BE47-4A29-9CEB-2ADB9E1A87ED

Q38696998-15CE05CA-9AD1-4704-A784-CF0386FF91F2

Q38696998-1950EC6C-C02B-473C-9C90-775D64520EF5

Q38696998-1BAE19D6-5BB6-4A17-9772-6AF38AA39B00

Q38696998-1F6718AC-E23F-4BB7-AD87-0FB3714DCBB2

P304

Q38696998-6BDE2CD8-96A0-44D4-9D19-7C98760ADDE5

P31

Q38696998-E09B73B3-A4FB-41EA-9555-3EC855856D2D

P356

Q38696998-73352FF9-C9F3-4EE4-9A40-F7DAA29C26D0

P433

Q38696998-86B71E16-32EB-4CAE-835B-4183AC45A0B9

P478

Q38696998-837E8A10-26D3-4C8C-AA08-6C792909E8E2

P50

Q38696998-76BE6ABD-8444-4955-A39E-7C121A375106

P577

Q38696998-E7ED4D8B-4DE6-4EED-8AF1-395D5A3AAE9A

P698

Q38696998-E4701D68-126D-4F8D-BBC3-AFC2C715851F

P921

Q38696998-3529DD7E-3A6D-4B44-80C1-92DF3570812B

P356

P1433

Journal of Thrombosis and Haemostasis

P1476

Prothrombotic aspects of sickle cell disease

@en

P2093

R Pawlinski

http://www.w3.org/2001/XMLSchema#string

P2860

Platelet hyperactivity in sickle-cell disease: a consequence of hyposplenism.

Defective thrombus formation in mice lacking coagulation factor XII

Differential regulation of endothelial exocytosis of P-selectin and von Willebrand factor by protease-activated receptors and cAMP

A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo

Thrombin signalling and protease-activated receptors

P-selectin-mediated platelet-neutrophil aggregate formation activates neutrophils in mouse and human sickle cell disease.

Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury

Hydroxyurea therapy of a murine model of sickle cell anemia inhibits the progression of pneumococcal disease by down-modulating E-selectin

A pilot study of eptifibatide for treatment of acute pain episodes in sickle cell disease.

Crises in Sickle Cell Disease.

P304

1307-1316

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JTH.13717

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28671346

http://www.w3.org/2001/XMLSchema#string

P921

sickle-cell disease